METTL16 and gastric cancer: In summary, METTL16 promotes GC cell proliferation and tumor progression through m6A-mediated stabilization of Cyclin D1 and modulation of cuproptosis and histone-associated signaling, highlighting its potential as a therapeutic target in gastric cancer.